• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

A Young Child with a Devastating Facial Lesion

News
Poll

What disease, known in antiquity but largely eradicated from the developed world, caused this severe facial scarring?

An undernourished child presents with a facial lesion present for some months (Figure). The problem started as a gingival ulcer with facial edema and progressed to a necrotic black escar. After sloughing of the escar and the external cheek skin, the area finally healed with a scar and retraction over the course of the next weeks.

What is the most likely diagnosis?

A. ANUG (acute necrotizing gingivostomatitis
B. Noma (cancrum oris)
C. Gangosa
D. Leishmaniasis
Related Content
Millions of US Adults Have Multiple Forms of Eczema, Study Finds

Millions of US Adults Have Multiple Forms of Eczema, Study Finds

Sydney Jennings
March 21st 2025
Article

Nearly 1 in 10 US adults have eczema, with 18% experiencing multiple eczema conditions, researchers from the National Eczema Association reported.

Roflumilast Cream Shows Strong Tolerability in Patients with AD Failing Other Topicals: Daily Dose / image credit: ©New Africa/AdobeStock

Roflumilast Cream Shows Strong Tolerability in Patients with AD Failing Other Topicals: Daily Dose

Sydney Jennings
March 19th 2025
Article

Your daily dose of the clinical news you may have missed.

Topical Steroid Withdrawal: Study Identifies Mitochondrial Dysfunction as a Potential Target for Treatment

Topical Steroid Withdrawal: Study Identifies Mitochondrial Dysfunction as a Potential Target for Treatment

Sydney Jennings
March 18th 2025
Article

NIH researchers also proposed new diagnostic criteria that include a combination of major and minor symptoms, offering improved sensitivity for identifying TSW cases.

Povorcitinib Efficacy in 2 Pivotal Phase 3 Trials Will Support Global Regulatory Submission for Hidradenitis Suppurativa

Povorcitinib Efficacy in 2 Pivotal Phase 3 Trials Will Support Global Regulatory Submission for Hidradenitis Suppurativa

Grace Halsey
March 17th 2025
Article

Both trials met their primary endpoints, demonstrating a statistically significant improvement in HiSCR50 compared to placebo, with a favorable safety profile, according to Incyte.

Upadacitinib Demonstrates Superior Regional, Overall Efficacy vs Dupilumab in Atopic Dermatitis: Level Up Phase 3b/4 Trial Findings / image credit ©isavira/stock.adobe.com

Upadacitinib Demonstrates Superior Regional, Overall Efficacy vs Dupilumab in Atopic Dermatitis: Level Up Phase 3b/4 Trial Findings

Grace Halsey
March 14th 2025
Article

Dupilumab-treated participants with recalcitrant head and neck symptoms who were switched to upadacitinib rapidly reached EASI 75 and steadily improved, among other findings.

Atopic Dermatitis of Childhood Onset Significantly Impacts "Life Trajectory" According to Scars of Life Survey

Atopic Dermatitis of Childhood Onset Significantly Impacts "Life Trajectory" According to Scars of Life Survey

Grace Halsey
March 12th 2025
Article

The impact of childhood onset AD on adult psychosocial experience, including employment and the decision to become a parent, is profound, this study reveals.

© 2025 MJH Life Sciences

All rights reserved.